Viewing Study NCT02067793

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-02-28 @ 8:19 AM
Study NCT ID: NCT02067793
Status: COMPLETED
Last Update Posted: 2016-03-17
First Post: 2014-02-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder
Sponsor: Naurex, Inc, an affiliate of Allergan plc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Major Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NRX-1074 View
None NMDA Receptor Modulator View
None Major Depressive Disorder View
None Glycine site modulator View